| NCT Number | NCT07221747 |
| Lead Sponsor | Georgetown University
Collaborators: Center for the Development of People, Centers for Disease Control and Prevention, Elizabeth Glaser Pediatric AIDS Foundation, Healthqual, Johns Hopkins Research Project, Malawi, Johns Hopkins Bloomberg School of Public Health, Blantyre District Health Office, Malawi, Lilongwe District Health Office, Malawi, Lighthouse Trust, Ministry of Health, Malawi, National AIDS Commission, Malawi, Pakachere Institute of Health and Development Communication, Partners in Hope, Inc., University of North Carolina, Chapel Hill, United States President's Emergency Plan for AIDS Relief, Washington University School of Medicine, Clinton Health Access Initiative Inc., Quantitative Engineering Design |
| Conditions | Oral Pre-exposure Prophylaxis (PrEP), Long-acting Injectable Cabotegravir for PrEP |
| Enrollment | 9,900 participants |
| Start Date | 2026-02-16 |
| Primary Completion | 2026-08-31 (estimated) |
| Study Completion | 2026-11 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-04 |